Search

Author/Creator Looman, Jim

1. ACTR-39. TWO-YEAR RESULTS OF THE INTELLANCE 2/EORTC TRIAL 1410 RANDOMIZED PHASE II STUDY ON DEPATUX–M ALONE, DEPATUX-M COMBINED WITH TEMOZOLOMIDE (TMZ) AND EITHER TMZ OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA (NCT02343406. (5th November 2018)

Authors:
van den Bent, Martin; French, Pim; Eoli, Marica; Sepulveda, Juan; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul; Weller, Michael; de Heer, Iris; Looman, Jim; Dey, Jyotirmoy; Krause, Scott; Xiong, Hao; Ansell, Peter; Nuyens, Sarah; Brilhante, Joana; Spruyt, Maarten...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 8 (1st July 2020)

Authors:
van den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; de Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 8(2021)
Page Start:
1415
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Issue 1 (9th December 2019)

Authors:
Hoogstrate, Youri; Vallentgoed, Wies; Kros, Johan M; de Heer, Iris; de Wit, Maurice; Eoli, Marica; Sepulveda, Juan Manuel; Walenkamp, Annemiek M E; Frenel, Jean-Sebastien; Franceschi, Enrico; Clement, Paul M; Weller, Micheal; van Royen, Martin E; Ansell, Peter; Looman, Jim; Bain, Earle; Morfouace...
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. HGG-15. PHASE 2 NESTED COHORT STUDY OF DEPATUXIZUMAB MAFODOTIN IN CHILDREN WITH HIGH GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA WITH EGFR AMPLIFICATION. Issue 2 (22nd June 2018)

Authors:
van den Bent, Martin; Dinjens, Winand; Golfinopoulos, Vassilis; Ansell, Peter; Dungey, Fiona; de Geus, Jan Peter; Bain, Earle; Looman, Jim; Xiong, Hao; Hargrave, Darren
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma. (April 2021)

Authors:
Clement, Paul M.J.; Dirven, Linda; Eoli, Marica; Sepulveda-Sanchez, Juan M.; Walenkamp, Annemiek M.E.; Frenel, Jean S.; Franceschi, Enrico; Weller, Michael; Chinot, Olivier; De Vos, Filip Y.F.L.; Whenham, Nicolas; Sanghera, Paul; Looman, Jim; Kundu, Madan G.; Peter de Geus, Jan; Nuyens, Sarah; Sp...
Journal:
European journal of cancer
Issue:
Volume 147(2021)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 5 (20th November 2019)

Authors:
Van Den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; De Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 5(2020)
Page Start:
684
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗